期刊
BIOMEDICINES
卷 9, 期 11, 页码 -出版社
MDPI
DOI: 10.3390/biomedicines9111732
关键词
acute respiratory distress syndrome; pulmonary lymphatics; influenza virus; corona virus; pulmonary edema; acute respiratory distress syndrome (ARDS) treatment
This review discusses pulmonary changes and treatment options for ARDS induced by viruses, focusing on the potential role of pulmonary lymphatics in the pathology. Although hyaluronan may play a role in ARDS, promising pharmacological treatments are unlikely due to the limited role of drugs in lymphedema therapy.
Acute respiratory distress syndrome (ARDS) is a serious affection of the lung caused by a variety of pathologies. Great interest is currently focused on ARDS induced by viruses (pandemic influenza and corona viruses). The review describes pulmonary changes in ARDS and specific effects of the pandemic viruses in ARDS, and summarizes treatment options. Because the known pathogenic mechanisms cannot explain all aspects of the syndrome, the contribution of pulmonary lymphatics to the pathology is discussed. Organization and function of lymphatics in a healthy lung and in resorption of pulmonary edema are described. A future clinical trial may provide more insight into the role of hyaluronan in ARDS but the development of promising pharmacological treatments is unlikely because drugs play no important role in lymphedema therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据